DR. JOHN JAMES LARKIN, MD

Plain English
This study looked at how much pharmaceutical companies paid general practices in England between 2015 and 2022. Payments increased significantly from £2.5 million in 2015 to £7.5 million in 2022, with one company, Chiesi, responsible for over half of that amount. This is important because it raises questions about whether these payments could influence doctors' prescribing choices, potentially affecting patient care. Who this helps: This helps patients and doctors by highlighting the need for transparency in pharmaceutical payments to practices.

Plain English
In a study that followed patients with advanced melanoma for nearly nine years, researchers found that those treated with nivolumab had significantly longer periods without their cancer returning compared to those treated with ipilimumab. Specifically, the median time without cancer recurrence was 61.1 months for nivolumab patients, compared to 24.2 months for ipilimumab patients, with 9-year recurrence-free survival rates of 44% and 37%, respectively. This research is important because it shows that nivolumab offers better long-term outcomes for people with resected melanoma, meaning they may live healthier and longer lives without their cancer coming back. Who this helps: This helps patients with advanced melanoma and their doctors.

Plain English
This study looked at the effectiveness and side effects of two cancer drugs, ipilimumab and nivolumab, in treating advanced cases of kidney cancer, particularly focusing on both common and rare types. Out of 154 patients treated, those with the common type (clear cell renal cell carcinoma) had an average overall survival of about 31.9 months, while patients with rare types had about 25.9 months. The research found that severe side effects led to better survival outcomes, especially for patients receiving high doses of steroids. Who this helps: This information benefits both patients with advanced kidney cancer and their doctors by guiding treatment decisions.

Plain English
This study looked at using ChatGPT, an AI tool, to create a carbon footprint calculator for dental practices. Researchers tested three methods of prompting the AI and found that using structured prompts significantly improved the accuracy and relevance of carbon emissions estimates. The best performance included detailed recommendations that matched established guidelines, showing that AI can help dental practices better understand and reduce their environmental impact. Who this helps: This helps dental practices, especially those without existing expertise in measuring their carbon footprint.

Plain English
This study looked at the placement of chest ports, which are devices used for long-term access to veins, at outpatient centers instead of traditional hospital settings. Researchers reviewed data from 47 centers, finding that 5,890 ports were placed, mainly for chemotherapy, with an average procedure time of 29 minutes and low pain levels (average score of 0.86 out of 10). Importantly, there were minimal complications, suggesting that this method is both safe and effective for patients needing long-term vascular access. Who this helps: This benefits patients needing chemotherapy or other intravenous treatments by providing a safer and more accessible option for port placement.

Plain English
This study looked at a case where a 68-year-old woman faced a sudden heart problem during a procedure to remove a device from her heart. After a part of her heart muscle was damaged, she developed a serious leak in her tricuspid valve. Doctors quickly fixed this issue using a new technique within 48 hours, marking it as the first successful emergency repair of this kind after such a complication, showing that immediate treatments can help critically ill patients when surgery is not an option. Who this helps: This benefits patients with heart device complications and their doctors.

Plain English
This study looked at the genetic differences between two less common types of kidney cancer: papillary renal cell carcinoma (pRCC) and chromophobe renal cell carcinoma (ChRCC), analyzing data from 164 tumor-normal pairs. The researchers discovered unique genetic patterns for each type, including how these patterns might affect how the tumors grow and how the body’s immune system responds to them. Understanding these differences is important because it can lead to better treatment options and improve outcomes for patients with these cancers. Who this helps: This helps patients with papillary and chromophobe kidney cancers.

Plain English
This study looked at how effective and safe a treatment called Stereotactic Radiosurgery (SRS) is for patients with brain metastases from melanoma. Out of 81 patients, the average survival time after treatment was about 17.6 months, and only 16% experienced bleeding within 90 days, which is lower than expected. These results are important because they can help doctors predict survival outcomes based on specific factors, like patients' performance status and levels of a certain enzyme (LDH). Who this helps: This benefits patients with metastatic melanoma and their doctors by providing better insights into treatment outcomes.

Plain English
This research looked at different types of knee osteoarthritis (OA) by measuring various proteins called cytokines in the blood of 277 participants over two years. The study found that the level of these cytokines changed quite a bit over time and did not consistently reflect the different types of OA, but one specific cytokine, IL-1ra, rose significantly in patients with the inflammatory type of OA, showing a 36% increase after 12 months and a 40% increase after 24 months compared to another type. Understanding these changes could help improve how doctors treat knee OA by identifying which patients have the inflammatory type. Who this helps: This helps patients with knee osteoarthritis and their doctors in tailoring more effective treatment strategies.

Plain English
This study looked at the environmental impact of two types of home kidney treatment: Automated Peritoneal Dialysis (APD) and Continuous Ambulatory Peritoneal Dialysis (CAPD). It found that APD generates more carbon emissions—about 3,267 kg per year compared to 2,975 kg for CAPD—mainly due to higher electricity use and plastics. This is important because it shows how we can improve kidney care by reducing waste and focusing on more sustainable practices that benefit both patient health and the environment. Who this helps: Patients with kidney failure and healthcare providers focused on sustainable treatment options.

Plain English
This study looked at the environmental impact of two kidney failure treatments in Italy: haemodialysis (HD) and online haemodiafiltration (OLHDF). Researchers found that both methods have similar greenhouse gas emissions, with HD at 4427 kg of CO2 and OLHDF at 4548 kg per patient each year. The majority of emissions came from travel (71%) and the procurement of medical supplies (21%), highlighting the need for better transport and resource management to make these treatments more sustainable. Who this helps: This research benefits patients by informing better choices for kidney treatment and reducing environmental harm.

Plain English
This study looked at ways to redesign peritoneal dialysis (PD) products to make them more environmentally friendly. Researchers found that by using renewable energy and more sustainable materials, they could significantly reduce carbon emissions from these products, with some items seeing reductions of over 40%—for example, a 63% reduction for automated PD sets and 87% for the PD machine. This is important because it helps healthcare systems lower their carbon footprint while still providing essential treatment for kidney disease. Who this helps: This benefits patients requiring peritoneal dialysis and healthcare providers aiming for sustainable practices.

Plain English
This study looked at how interactions between doctors and the pharmaceutical industry affect the prescribing of pain medications for chronic nonmalignant pain (CNMP). It found that out of 44 comparisons, 38 (86%) showed that doctors who received payments or promotions from pharmaceutical companies prescribed more pain medications and spent more on opioids, with an average increase of about $4,785 per year per doctor. This matters because it highlights how external influences can lead to higher medication use and costs, potentially affecting patient care. Who this helps: Patients who manage chronic pain and their healthcare providers.

Plain English
This study looked at how Dutch hospitals dispose of old hemodialysis machines as they switch to newer technology. Researchers interviewed 15 professionals from 11 hospitals, finding five main ways machines are handled: disposal, donation, reuse, sale, and recycling. They discovered that decisions are mainly based on cost, with little formal guidance on how to manage the environmental and social impacts, which highlights the need for better practices. Who this helps: This helps hospitals improve their waste management practices and enhances patient care by promoting sustainability.

Plain English
This study looked at the effectiveness of two drugs, savolitinib and durvalumab, for treating metastatic papillary renal cancer (PRC) in patients who either hadn't received treatment before or had been previously treated. They found that, out of 41 patients, 34% responded to the treatment overall, while 53% of those with a specific type of this cancer responded. The average survival time was about 18 months for all patients and about 27 months for those with the targeted type. This matters because it shows that this drug combination might help extend the lives of patients with this particular cancer, and tests on genetic material from tumors could help predict which patients will benefit most. Who this helps: Patients with metastatic papillary renal cancer.

Plain English
This study looked at how soon patients can start moving after having a specific type of brain hemorrhage (aSAH). Out of 102 patients, 90 people (88.2%) were able to start moving within the first 14 days, but a significant number faced challenges due to health issues, like neurological instability. By two weeks, 65.2% of those in good condition could walk independently, while only 12.9% of those in poor condition could do the same, highlighting the need for careful monitoring while patients regain mobility. Who this helps: This research benefits patients recovering from aSAH and the healthcare professionals caring for them.

Plain English
This study looked at what various stakeholders in Ireland think about creating a list of essential medicines that the country should provide to meet its health needs. Thirteen people were interviewed, and they identified three main topics: the purpose of the list, the challenges and supports for creating it, and how to develop and implement it. The participants agreed that this list would help ensure that everyone has access to vital medicines, although opinions varied on whether it should lower costs for patients. Who this helps: This helps patients by ensuring they have access to important medications.

Plain English
This study looked at a biomarker called KIM-1 in patients with advanced papillary and clear cell kidney cancers. The researchers found that KIM-1 levels were higher in patients with papillary kidney cancer (7,835 pg/ml) compared to those with clear cell kidney cancer (5,470 pg/ml), and that KIM-1 levels decreased during treatment (by 59.2% in clear cell and 32% in papillary). Importantly, higher KIM-1 levels at the start of treatment were linked to shorter survival times in clear cell kidney cancer patients. Who this helps: This research benefits kidney cancer patients and doctors by providing insights into how KIM-1 can be used to monitor the disease and treatment response.

Plain English
This study looked at the long-term effects of a treatment called lifileucel, which is a type of cell therapy for patients with advanced melanoma that hasn't responded to other treatments. Over five years, about 31.4% of patients showed a reduction in their tumors, and the average survival time was 13.9 months, with 19.7% of patients alive after five years. The treatment also had manageable side effects that improved quickly after administration, indicating its long-term benefits and safety. Who this helps: This provides hope for patients with advanced melanoma who have few effective treatment options.

Plain English
This study looked at an online therapy program designed to help working women manage hot flushes and night sweats during menopause. Out of 426 participants who started the program, 213 continued to the first session, and 62 completed all sessions, resulting in significant improvements in their symptoms and mental health. This matters because these symptoms can greatly affect women's work and social lives, and online therapy offers a convenient way to get help. Who this helps: This benefits menopausal women dealing with uncomfortable symptoms, especially those who work.

Plain English
This study looked at how certain biological markers in the blood and tumor tissue can predict the chances of recurrence in patients with advanced melanoma who were treated with immunotherapy. Researchers found that 16.2% of patients had a specific type of DNA in their blood (called ctDNA) before treatment that was linked to nearly double the risk of their cancer coming back, with a reliable specificity of 87%. These findings are important because they can help doctors identify which patients are at higher risk for recurrence and may need closer monitoring after treatment. Who this helps: This helps patients with melanoma as well as their doctors by providing better tools for predicting and managing cancer recurrence.

Plain English
This study looked at tiny worms (nematodes) and their bacteria found in Florida's grasslands to see if they could help control harmful nematodes that damage grass. Researchers found several types of these nematodes and their bacteria, and when tested, some bacterial extracts killed over 87% of the grass root-knot nematodes and between 44% to 100% of the sting nematodes, depending on the concentration. This is important because it shows a new potential way to protect turfgrass from harmful pests using natural biological methods. Who this helps: This benefits turfgrass farmers and landscapers who deal with pest problems.

Plain English
This study looked at how different types of containers used to hold the acid solution for hemodialysis affect the environment. It found that small plastic canisters have a carbon footprint 1.63 times higher than flexible bags and 2.63 times higher than large storage tanks. By choosing storage tanks, dialysis centers can potentially reduce their environmental impact significantly. Who this helps: This benefits dialysis centers and patients by promoting more sustainable practices in kidney care.

Plain English
This study looked at late-onset side effects in patients with advanced melanoma who were treated with immune checkpoint inhibitors. Researchers found that nearly 15% of the 246 patients studied developed these late side effects, such as skin rashes, colitis, and joint pain, at least three months after treatment, and about 2% experienced even more delayed effects after 12 months. Understanding these late-onset issues is important because they can cause significant challenges in treatment and quality of life. Who this helps: This helps patients undergoing treatment for advanced melanoma and their doctors by highlighting potential risks.

Plain English
This study looked at an AI system called the Anemia Control Model (ACM) that helps doctors manage anemia in patients undergoing dialysis. The research showed that using ACM leads to better health outcomes, providing patients with more quality-adjusted life years (QALYs) while also reducing treatment costs by about €38,423 per patient compared to standard care. This is important because it indicates that the ACM can improve care for patients while saving the healthcare system money. Who this helps: This helps patients on dialysis and their doctors.

Plain English
This study looked at the information available on social media in the UK about hormone replacement therapy (HRT) for menopause. Researchers found that 67.2% of the claims made about HRT were not in line with official health guidelines, and 77.2% of those claims came from sources with potential conflicts of interest. This is important because it shows that much of the information shared online may be misleading, which can affect how well patients and doctors understand and use HRT. Who this helps: Patients and doctors seeking accurate information about menopause treatments.

Plain English
This study looked at the environmental impact of supplies used in peritoneal dialysis (PD) in Italy, focusing on how the procurement of items like dialysis bags and machines contributes to carbon emissions. The findings revealed that procurement activities can lead to significant emissions, with the 5L dialysis bag being the biggest contributor at 1,515 kg of carbon dioxide equivalent per year, followed by the 2L bag at 457 kg. This matters because most of the environmental impact comes from a few items, and improving how they are made and transported could significantly reduce emissions in healthcare. Who this helps: Patients and healthcare providers seeking more sustainable treatment options.

Plain English
This study examined how brain metastases (BrM) affect the outcomes of treatments for patients with advanced kidney cancer (renal cell carcinoma or RCC). Researchers reviewed 62 studies involving 4,637 patients and found that those with both RCC and BrM generally had poorer survival rates compared to those without BrM. Some multimodal treatments that combined systemic and local therapies showed benefits in controlling both brain and body cancer, highlighting the need for better data to inform treatment decisions. Who this helps: This research helps doctors and patients dealing with kidney cancer that has spread to the brain.

Plain English
This study looked at how to make kidney care, specifically hemodialysis, more environmentally friendly. Researchers found that reducing patient travel and optimizing resource use could significantly lower carbon emissions, with travel optimization alone saving a substantial amount. These changes not only help the environment but also ensure that patients still receive effective care. Who this helps: This benefits kidney disease patients and healthcare providers by making treatment more sustainable.

Plain English
This study looked at injuries and illnesses experienced by male and female sailors during the third season of the SailGP competition, which took place from April 2022 to May 2023. The researchers found that there were 40 injuries among 32 sailors, with injuries occurring more often during competitions (32.6 injuries per 1,000 hours) compared to training (2.62 per 1,000 hours). Notably, female sailors faced higher rates of both injuries and illnesses, with knee injuries being the most common. Who this helps: This information benefits sailors and sports doctors by highlighting the need for better injury prevention strategies in professional sailing.

Plain English
This study looked at how cultural backgrounds affect how medical students respond to feedback while training at three different campuses around the world. Researchers interviewed 57 final-year medical students and found that cultural factors, like family and school influences, shaped their experiences more than their national identities. Notably, female students often felt humiliated by negative feedback, while some males saw it as a necessary challenge. Improving feedback methods is crucial for better training environments, especially by recognizing students' unique backgrounds. Who this helps: Patients and medical students benefit from more supportive feedback practices in their training.

Plain English
This study looks at the social aspects of managing end-stage kidney disease, which affects not just patients but also caregivers and healthcare providers. The researchers found that while there are already some insights into these social aspects, the information is disorganized and incomplete. By reviewing existing research, they aim to create a clear picture of how kidney care affects people's lives and identify what needs more attention, which is important for improving care and policies. Who this helps: This benefits patients, caregivers, and healthcare professionals involved in kidney care.

Plain English
This study looked at two methods of providing a key ingredient used in haemodialysis, highlighting their environmental impacts. The researchers found that using the Granumix central delivery system is much better for the environment, reducing the potential for climate change by 30% and freshwater pollution by 15%, compared to the traditional bag method. This is important because it shows that healthcare can be made more sustainable, reducing waste and emissions. Who this helps: This benefits patients, healthcare facilities, and the environment.

Plain English
Researchers created a large international database called Apollo, which collects important information from dialysis patients across the globe. The database includes data from over 543,000 patients in 40 countries and contains nearly 36 million lab results and 140 million treatment records. This is significant because it allows for better research and analysis, leading to improved understanding and treatment of kidney disease. Who this helps: This benefits kidney disease patients and healthcare providers.

Plain English
This study examined ways to make kidney care more environmentally friendly by looking at existing methods that have been used in different types of kidney treatment. Out of over 2,500 records, researchers found 95 studies focused on sustainability, with the most common efforts in haemodialysis, which had 58 interventions aimed at reducing water use, managing waste, and improving energy efficiency. These findings are important because they highlight both the benefits and challenges of implementing sustainable practices in kidney care, especially in wealthier areas, while showing there's a significant opportunity for improvement in less resourced settings. Who this helps: This helps patients and healthcare providers by promoting greener and more efficient kidney treatment options.

Plain English
This study looked at older patients (75 and up) who had surgery for colorectal cancer to understand their recovery outcomes. Researchers found that 29.4% of patients with serious health issues (measured by a tool named CCI) faced major complications or died within 30 days, compared to 11.9% of those with fewer health issues. The findings show that while surgery can be safe for elderly patients, those with more health problems are at a higher risk for complications, highlighting the importance of careful health assessments before surgery. Who this helps: This benefits older patients facing surgery for colorectal cancer and their doctors in making informed surgical decisions.

Plain English
This study looked at brain cells collected from patients with epilepsy to understand how they function and how they relate to seizure activity. Researchers found that the samples contained various RNA types from different cell types, and these gene expressions changed based on where the electrodes were placed in the brain. This matters because it helps us understand the local brain environment during seizures, which could improve surgical decisions and identify new treatments for patients whose epilepsy doesn't respond to medication. Who this helps: This helps patients with drug-resistant epilepsy and their doctors.

Plain English
This study looked at what happens when cancer patients try immune checkpoint inhibitors (ICIs) again after they stopped working the first time. It reviewed 51 studies and found that in melanoma, some patients had good responses after re-treatment, while results were mixed for other cancers like kidney cancer and lung cancer. This research is important because it helps doctors understand that while some patients may benefit from trying ICIs again, the evidence is still not strong enough to make definitive recommendations. Who this helps: This helps cancer patients considering retreatment options and their doctors in making informed decisions.